P2RY12 and myocardial infarction: Ticagrelor,a P2Y12 platelet inhibitor, is prescribed for individualswith prior myocardial infarction (MI) or with acute coronary syndrome(ACS) to diminish the risk of future MI, stroke, and cardiovascularmortality.